{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T23:28:07Z","timestamp":1786577287861,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.vhri.2022.09.003","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T01:29:44Z","timestamp":1667525384000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Economic Impact Analysis of Incorporation of Elecsys sFlt-1\/PlGF Ratio Into Routine Practice for the Diagnosis and Follow-Up of Pregnant Women With Suspected Preeclampsia in Argentina"],"prefix":"10.1016","volume":"34","author":[{"given":"Osvaldo Ulises","family":"Garay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo Germ\u00e1n","family":"Gui\u00f1az\u00fa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Basualdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Di Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Zilberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Voto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/j.vhri.2022.09.003_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention [published correction appears in Int J Gynaecol Obstet. 2019;146(3):390-391]","volume":"145","author":"Poon","year":"2019","journal-title":"Int J Gynecol Obstet"},{"issue":"7","key":"10.1016\/j.vhri.2022.09.003_bib2","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia: pathophysiology, challenges, and perspectives [published correction appears in Circ Res. 2020;126(1):e8]","volume":"124","author":"Rana","year":"2019","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.vhri.2022.09.003_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","article-title":"Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice","volume":"72","author":"Brown","year":"2018","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.vhri.2022.09.003_bib5","first-page":"1122","article-title":"Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.vhri.2022.09.003_bib6","doi-asserted-by":"crossref","first-page":"133.e1","DOI":"10.1016\/j.ajog.2007.12.020","article-title":"Identification of severe maternal morbidity during delivery hospitalizations, United States, 1991-2003","volume":"199","author":"Callaghan","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.vhri.2022.09.003_bib7","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/AOG.0b013e3181a45b25","article-title":"Hypertensive disorders and severe obstetric morbidity in the United States","volume":"113","author":"Kuklina","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"suppl 1","key":"10.1016\/j.vhri.2022.09.003_bib9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/1471-0528.12629","article-title":"Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health","volume":"121","author":"Abalos","year":"2014","journal-title":"BJOG"},{"issue":"3","key":"10.1016\/j.vhri.2022.09.003_bib11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ajog.2017.04.032","article-title":"Short-term costs of preeclampsia to the United States healthcare system","volume":"217","author":"Stevens","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.vhri.2022.09.003_bib12","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejogrb.2014.04.033","article-title":"Care-as-usual provided to formerly preeclamptic women in the Netherlands in the next pregnancy: health care consumption, costs and maternal and child outcome","volume":"179","author":"Delahaije","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"10.1016\/j.vhri.2022.09.003_bib13","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1097\/AOG.0000000000003581","article-title":"Maternal and infant health care costs related to preeclampsia","volume":"134","author":"Hao","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.vhri.2022.09.003_bib15","first-page":"2317","article-title":"Diagnosis and management of preeclampsia","volume":"70","author":"Wagner","year":"2004","journal-title":"Am Fam Physician"},{"issue":"4","key":"10.1016\/j.vhri.2022.09.003_bib16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/EJA.0000000000000044","article-title":"Preeclampsia: pathophysiology, old and new strategies for management","volume":"31","author":"Stocks","year":"2014","journal-title":"Eur J Anaesthesiol"},{"issue":"9741","key":"10.1016\/j.vhri.2022.09.003_bib17","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","article-title":"Pre-eclampsia","volume":"376","author":"Steegers","year":"2010","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.vhri.2022.09.003_bib18","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nrneph.2014.102","article-title":"Pre-eclampsia part 1: current understanding of its pathophysiology","volume":"10","author":"Chaiworapongsa","year":"2014","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1016\/j.vhri.2022.09.003_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.vhri.2022.09.003_bib20","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/1471-2393-14-324","article-title":"Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol","volume":"14","author":"Hund","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"issue":"2","key":"10.1016\/j.vhri.2022.09.003_bib21","first-page":"261","article-title":"Prediction of adverse outcomes by common definitions of hypertension in pregnancy","volume":"97","author":"Zhang","year":"2001","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.vhri.2022.09.003_bib22","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1471-0528.2009.02480.x","article-title":"Introducing maternal morbidity audit in the Netherlands","volume":"117","author":"van Dillen","year":"2010","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.vhri.2022.09.003_bib23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/uog.21869","article-title":"From first-trimester screening to risk stratification of evolving pre-eclampsia in second and third trimesters of pregnancy: comprehensive approach","volume":"55","author":"Poon","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.vhri.2022.09.003_bib24","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J\u00a0Clin Invest"},{"issue":"9","key":"10.1016\/j.vhri.2022.09.003_bib25","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/hr.2010.92","article-title":"Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia","volume":"33","author":"Molvarec","year":"2010","journal-title":"Hypertens Res"},{"issue":"4","key":"10.1016\/j.vhri.2022.09.003_bib26","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/HYPERTENSIONAHA.119.12739","article-title":"Randomized interventional study on prediction of preeclampsia\/eclampsia in women with suspected preeclampsia","volume":"74","author":"Cerdeira","year":"2019","journal-title":"Hypertension"},{"issue":"18","key":"10.1016\/j.vhri.2022.09.003_bib27","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1080\/14767058.2016.1242122","article-title":"Budget impact analysis of sFlt-1\/PlGF ratio as prediction test in Italian women with suspected preeclampsia","volume":"30","author":"Frusca","year":"2017","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.vhri.2022.09.003_bib28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.preghy.2018.04.014","article-title":"Economic evaluation of sFlt-1\/PlGF ratio test in pre-eclampsia prediction and diagnosis in two Brazilian hospitals","volume":"13","author":"Figueira","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.vhri.2022.09.003_bib29","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4096847","article-title":"sFlt-1\/PlGF ratio as a predictive marker in women with suspected preeclampsia: an economic evaluation from a Swiss perspective","volume":"2019","author":"Hodel","year":"2019","journal-title":"Dis Markers"},{"issue":"1","key":"10.1016\/j.vhri.2022.09.003_bib30","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1186\/s12913-018-3406-1","article-title":"Economic assessment of the use of the sFlt-1\/PlGF ratio test to predict preeclampsia in Germany","volume":"18","author":"Schlembach","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.vhri.2022.09.003_bib31","author":"Lapidus"},{"key":"10.1016\/j.vhri.2022.09.003_bib32","doi-asserted-by":"crossref","first-page":"f1049","DOI":"10.1136\/bmj.f1049","article-title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement","volume":"346","author":"Husereau","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.vhri.2022.09.003_bib33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jval.2013.08.2291","article-title":"Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force","volume":"17","author":"Sullivan","year":"2014","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.vhri.2022.09.003_bib40","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/ije\/dym062","article-title":"Decision modelling for health economic evaluation. A Briggs, M Sculpher, K Claxton","volume":"36","author":"Caldwell","year":"2007","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vhri.2022.09.003_bib42","article-title":"Public health perspectives of preeclampsia in developing countries: implication for health system strengthening","volume":"2011","author":"Osungbade","year":"2011","journal-title":"J\u00a0Pregnancy"},{"issue":"10","key":"10.1016\/j.vhri.2022.09.003_bib43","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/1471-0528.12259","article-title":"Cost and resource implications with serum angiogenic factor estimation in the triage of pre-eclampsia","volume":"120","author":"Schnettler","year":"2013","journal-title":"BJOG"},{"issue":"6","key":"10.1016\/j.vhri.2022.09.003_bib44","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/uog.15997","article-title":"sFlt-1\/PlGF ratio test for pre-eclampsia: an economic assessment for the UK","volume":"48","author":"Vatish","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.vhri.2022.09.003_bib45","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/10641955.2014.982331","article-title":"Influence of the sFlt-1\/PlGF ratio on clinical decision-making in women with suspected preeclampsia--the PreOS study protocol","volume":"34","author":"Hund","year":"2015","journal-title":"Hypertens Pregnancy"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109922001704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109922001704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T20:14:11Z","timestamp":1761941651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109922001704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":34,"alternative-id":["S2212109922001704"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2022.09.003","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Economic Impact Analysis of Incorporation of Elecsys sFlt-1\/PlGF Ratio Into Routine Practice for the Diagnosis and Follow-Up of Pregnant Women With Suspected Preeclampsia in Argentina","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2022.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society for Health Economics and Outcomes Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}